Revelation Biosciences (REVB) Reports Q3 Loss of $0.42

Revelation Biosciences (NASDAQ: REVB) reported Q3 EPS of ($0.42).

For earnings history and earnings-related data on Revelation Biosciences (REVB) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
• RBC Capital Downgrades Hermes International (RMS:FP) (HESAY) to Sector Perform